Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Accenture
Dow
Fish and Richardson
Healthtrust
Medtronic
Cerilliant
Julphar
US Army
UBS
Merck

Generated: February 18, 2018

DrugPatentWatch Database Preview

Septodont Company Profile

« Back to Dashboard

What is the competitive landscape for SEPTODONT, and what generic alternatives to SEPTODONT drugs are available?

SEPTODONT has eight approved drugs.

There are five US patents protecting SEPTODONT drugs.

There are thirty patent family members on SEPTODONT drugs in twenty countries.

Summary for Septodont
International Patents:30
US Patents:5
Tradenames:8
Ingredients:8
NDAs:8

Drugs and US Patents for Septodont

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Septodont BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE bupivacaine hydrochloride; epinephrine bitartrate INJECTABLE;INJECTION 077250-001 Sep 27, 2006 AP RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Septodont Holding ORAVERSE phentolamine mesylate INJECTABLE;INJECTION 022159-001 May 9, 2008 RX Yes Yes 7,575,757 ➤ Try a Free Trial Y ➤ Try a Free Trial
Septodont Inc ISOCAINE HYDROCHLORIDE W/ LEVONORDEFRIN levonordefrin; mepivacaine hydrochloride INJECTABLE;INJECTION 084697-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial
Septodont Holding ORAVERSE phentolamine mesylate INJECTABLE;INJECTION 022159-001 May 9, 2008 RX Yes Yes 7,229,630 ➤ Try a Free Trial Y ➤ Try a Free Trial
Septodont Inc PRILOCAINE HYDROCHLORIDE prilocaine hydrochloride INJECTABLE;INJECTION 079235-001 Sep 29, 2010 RX No Yes ➤ Try a Free Trial ➤ Try a Free Trial
Septodont Inc LIDOCAINE lidocaine OINTMENT;TOPICAL 040911-001 May 23, 2011 AT RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Septodont Holding ORAVERSE phentolamine mesylate INJECTABLE;INJECTION 022159-001 May 9, 2008 RX Yes Yes 7,569,230 ➤ Try a Free Trial ➤ Try a Free Trial
Septodont Holding ORAVERSE phentolamine mesylate INJECTABLE;INJECTION 022159-001 May 9, 2008 RX Yes Yes 6,872,390 ➤ Try a Free Trial Y ➤ Try a Free Trial
Septodont OCTOCAINE epinephrine; lidocaine hydrochloride INJECTABLE;INJECTION 084048-001 Approved Prior to Jan 1, 1982 AP RX No Yes ➤ Try a Free Trial ➤ Try a Free Trial
Septodont OCTOCAINE epinephrine; lidocaine hydrochloride INJECTABLE;INJECTION 084048-002 Approved Prior to Jan 1, 1982 AP RX No Yes ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Non-Orange Book US Patents for Septodont

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
6,432,401 Local anesthetic methods and kits ➤ Try a Free Trial
7,261,889 Local anesthetic methods and kits ➤ Try a Free Trial
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents for Septodont Drugs

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fish and Richardson
Express Scripts
Deloitte
US Army
McKesson
Cipla
Accenture
Daiichi Sankyo
Julphar

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot